Literature DB >> 10223609

A reverse-phase, isocratic high-performance liquid chromatography assay for levofloxacin.

C M Tobin, J Sunderland, L O White, A P MacGowan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10223609     DOI： 10.1093/jac/43.3.434

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Vitreous penetration of levofloxacin in the uninflamed phakic human eye.

Authors:  E N Herbert; I A Pearce; J McGalliard; D Wong; C Groenewald
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy.

Authors:  P Villani; P Viale; L Signorini; B Cadeo; F Marchetti; A Villani; C Fiocchi; M B Regazzi; G Carosi
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

3.  Humanized Exposures of Cefiderocol, a Siderophore Cephalosporin, Display Sustained in vivo Activity against Siderophore-Resistant Pseudomonas aeruginosa.

Authors:  Islam M Ghazi; Marguerite L Monogue; Masakatsu Tsuji; David P Nicolau
Journal:  Pharmacology       Date:  2018-02-22       Impact factor: 2.547
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.